Arenberg DA - Search Results

1

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.

Daly ME, Singh N, Ismaila N, Antonoff MB, Arenberg DA, Bradley J, David E, Detterbeck F, Früh M, Gubens MA, Moore AC, Padda SK, Patel JD, Phillips T, Qin A, Robinson C, Simone CB 2nd. Daly ME, et al. Among authors: arenberg da. J Clin Oncol. 2022 Apr 20;40(12):1356-1384. doi: 10.1200/JCO.21.02528. Epub 2021 Dec 22. J Clin Oncol. 2022. PMID: 34936470 Review.

2

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. Arenberg DA, et al. J Clin Invest. 1996 Jun 15;97(12):2792-802. doi: 10.1172/JCI118734. J Clin Invest. 1996. PMID: 8675690 Free PMC article.

3

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.

Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM. Arenberg DA, et al. J Exp Med. 1996 Sep 1;184(3):981-92. doi: 10.1084/jem.184.3.981. J Exp Med. 1996. PMID: 9064358 Free PMC article.

4

The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer.

Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM. Arenberg DA, et al. J Leukoc Biol. 1997 Nov;62(5):554-62. doi: 10.1002/jlb.62.5.554. J Leukoc Biol. 1997. PMID: 9365108 Free article. Review.

5

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, Burdick MD, Glass MC, Iannettoni MD, Strieter RM. Arenberg DA, et al. J Clin Invest. 1998 Aug 1;102(3):465-72. doi: 10.1172/JCI3145. J Clin Invest. 1998. PMID: 9691082 Free PMC article.

6

Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.

White ES, Strom SR, Wys NL, Arenberg DA. White ES, et al. Among authors: arenberg da. J Immunol. 2001 Jun 15;166(12):7549-55. doi: 10.4049/jimmunol.166.12.7549. J Immunol. 2001. PMID: 11390510

7

RANTES expression is a predictor of survival in stage I lung adenocarcinoma.

Moran CJ, Arenberg DA, Huang CC, Giordano TJ, Thomas DG, Misek DE, Chen G, Iannettoni MD, Orringer MB, Hanash S, Beer DG. Moran CJ, et al. Among authors: arenberg da. Clin Cancer Res. 2002 Dec;8(12):3803-12. Clin Cancer Res. 2002. PMID: 12473593

8

Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.

White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA. White ES, et al. Among authors: arenberg da. Clin Cancer Res. 2003 Feb;9(2):853-60. Clin Cancer Res. 2003. PMID: 12576459 Free article.

9

Chemokines as therapeutic targets in non-small cell lung cancer.

White ES, Strieter RM, Arenberg DA. White ES, et al. Among authors: arenberg da. Curr Med Chem Anticancer Agents. 2002 May;2(3):403-17. doi: 10.2174/1568011024606406. Curr Med Chem Anticancer Agents. 2002. PMID: 12678740 Review.

10

Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Kong FM, Hayman JA, Griffith KA, Kalemkerian GP, Arenberg D, Lyons S, Turrisi A, Lichter A, Fraass B, Eisbruch A, Lawrence TS, Ten Haken RK. Kong FM, et al. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1075-86. doi: 10.1016/j.ijrobp.2006.01.051. Epub 2006 May 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16647222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page